Log in or Sign up for Free to view tailored content for your specialty!
Preventive Health News
Breast arterial calcification on mammograms may be marker for future heart disease risk
CHICAGO — The presence of breast arterial calcifications on routine mammograms may signal increased risk for atherosclerotic CVD later in life, according to research presented at the Annual Meeting of The Menopause Society.
Full results confirm potential breakthrough in HIV prevention
In June, Gilead Sciences announced that its investigational antiretroviral drug lenacapavir prevented 100% of new HIV infections during a phase 3 trial conducted among cisgender women in Africa.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: Discussing mammography risks 'does not seem to undermine' screening decisions
Informing patients of the benefit-harm balance associated with mammography screening is beneficial and did not hinder overall screening decisions, according to results of a national probability-based U.S. survey.
Vistagen announces new patents for investigational pherine nasal spray to treat migraine
A clinical-stage neuroscience-focused biopharmaceutical company has received new international patents related to an investigational neuroactive pherine nasal spray to potentially treat individuals with migraine.
Will new approvals, stronger recommendations improve RSV vaccine uptake?
After decades of RSV vaccine development, the approvals and recommendations were seen as landmark events in preventive medicine. Uptake was low, however — not unusual for first-year approvals, experts told Healio.
Twice-yearly shot prevents HIV in phase 3 trial, Gilead reports
Lenacapavir, an injectable antiretroviral drug approved by the FDA for HIV treatment, prevented 100% of new HIV infections among women in a phase 3 trial in Africa, demonstrating its efficacy as PrEP, Gilead Sciences said.
USPSTF: Screen older and at-risk postmenopausal women for osteoporosis
The U.S. Preventive Services Task Force has issued a draft recommendation stating that all women aged 65 years and older be screened for osteoporosis to prevent fractures.
Most women with menstrual migraine use acute treatments only
DENVER – Most with menstrual migraine utilize only acute treatments, rather than preventive measures, to address their symptoms, according to research presented at the American Academy of Neurology annual meeting.
WHO reports ‘major’ global increase in STIs
WHO reported a “major” increase in STIs in 2022, specifically highlighting an increase in syphilis and an insufficient decline in new HIV and viral hepatitis infections.
Screen men, not women, for intimate partner violence
SAN FRANCISCO — To identify and prevent intimate partner violence, screening men for perpetration may be more useful than screening women for victimization, according to data presented at the ACOG Annual Clinical & Scientific Meeting.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read